- Report
- October 2024
- 180 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 185 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 181 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- March 2025
- 193 Pages
Global
From €5174EUR$5,450USD£4,364GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- March 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- July 2024
- 175 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- July 2024
- 180 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Clinical Trials
- April 2024
- 450 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- October 2024
- 200 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- May 2024
- 485 Pages
Europe
From €7590EUR$7,995USD£6,402GBP
- Report
- March 2022
- 231 Pages
Global
From €2492EUR$2,625USD£2,102GBP
€4984EUR$5,250USD£4,204GBP
- Report
- May 2023
- 90 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- November 2023
- 250 Pages
Global
From €4747EUR$5,000USD£4,004GBP
- Report
- July 2022
- 227 Pages
Global
From €3323EUR$3,500USD£2,803GBP
€4747EUR$5,000USD£4,004GBP
- Report
- December 2024
- 85 Pages
Spain
From €3323EUR$3,500USD£2,803GBP
- Report
- August 2024
- 80 Pages
Japan
From €3323EUR$3,500USD£2,803GBP
- Report
- August 2023
- 73 Pages
Egypt
From €3323EUR$3,500USD£2,803GBP

Gynecological cancer is a type of cancer that affects the female reproductive system, including the uterus, cervix, ovaries, fallopian tubes, vagina, and vulva. It is the second most common type of cancer among women, and the most common cause of death from gynecological cancer is cervical cancer. Treatment for gynecological cancer typically involves surgery, chemotherapy, and radiation therapy.
Women's health is an important area of focus for gynecological cancer, as it is a major cause of death among women. Early detection and treatment are key to reducing the mortality rate of gynecological cancer, and women should be aware of the signs and symptoms of gynecological cancer. Regular screenings and preventive measures are also important for reducing the risk of developing gynecological cancer.
There are a number of companies in the gynecological cancer market, including Roche, Novartis, AstraZeneca, Merck, and Pfizer. These companies are involved in the development of treatments and therapies for gynecological cancer, as well as in the research and development of new treatments and therapies. Show Less Read more